Company · CIK 0001563880 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Trevi Therapeutics, Inc. · TRVI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 SForm 4 → | Sep 17, 4:55 pm EDT | Michael Thomas HeffernanDirector | 39,473 | $15.09 | $595,806 | 6,351 | −86.1% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 17, 4:55 pm EDT | Michael Thomas HeffernanDirector | 39,473 | $3.19 | $126,103 | 27,403 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 17, 4:55 pm EDT | Michael Thomas HeffernanDirector | 39,473 | — | — | 0 | — | 10b5-1 |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:28 pm EDT | Edward T MathersDirector | 35,000 | — | — | 35,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:05 pm EDT | Dominick ColangeloDirector | 35,000 | — | — | 35,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:05 pm EDT | David P MeekerDirector | 35,000 | — | — | 35,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:05 pm EDT | Anne VanlentDirector | 35,000 | — | — | 35,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:05 pm EDT | Michael Thomas HeffernanDirector | 35,000 | — | — | 35,000 | — |